Goffin and coworkers reported that MMP-9 degradation products were significantly higher in the serum of patients with penetrating CD and that selective anti-MMP-9 monoclonal antibodies reduced collagen deposition in a heterotopic xenograft mouse model of intestinal fibrosis (4). This evidence concerns the gene MMP9 and Cowden disease.